Pure Global

HbA1c - India CDSCO Medical Device Registration

HbA1c is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000049_f0db786141f00b78e5b1a8873c63a7ff_02db1901cdad2b3b18c1404133071897. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class B. The approving authority is Telangana.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c
UID: MFG/IVD/2021/000049_f0db786141f00b78e5b1a8873c63a7ff_02db1901cdad2b3b18c1404133071897

Device Class

Class B

Approving Authority

Telangana

Product Information

HbA1c reagent is intended for in vitro diagnostic use in the quantitative determination of HbA1c in blood

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing